mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.07 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.07 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.07 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.27 |
0.07 |
mRNA |
BRD-K29313308 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.07 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.052 |
0.07 |